U.S. Other Utilities Stock News

International Business Machines (IBM) is back in focus after reporting Q4 results with higher revenue and net income year over year, along with a new role supporting the U.S. Missile Defense Agency’s SHIELD program. See our latest analysis for International Business Machines. IBM’s share price has pulled back recently, with a 7 day share price return of 6.26% and a 30 day share price return of 4.16%. At the same time, the 1 year total shareholder return sits at 17.34% and the 5 year total...

If you are wondering whether LCI Industries is fairly priced or offering value right now, you are not alone. This article will walk through the key numbers that matter. The stock last closed at US$152.75, with returns of 2.3% over 7 days, 20.8% over 30 days, 22.9% year to date, 57.8% over 1 year, 49.1% over 3 years and 26.7% over 5 years. This naturally raises questions about what is already reflected in the current price. Recent coverage of LCI Industries has focused on how investors are...

BorgWarner (NYSE:BWA) declared a quarterly cash dividend, reaffirming its regular payout to shareholders. The board approval signals continued capital return through ongoing dividend distributions. BorgWarner focuses on powertrain and eMobility solutions for global automakers, with products that span combustion, hybrid, and electric vehicle technologies. For investors watching the auto components space, dividend decisions can be especially relevant as manufacturers and suppliers adjust...

Amphastar Pharmaceuticals recently reported that rising day-to-day expenses have outpaced revenue, causing its adjusted operating margin to contract by 4.3 percentage points. This margin pressure is particularly important for Amphastar, which operates with a relatively small revenue base and fewer distribution channels than larger drugmakers. We’ll examine how this adjusted operating margin compression shapes Amphastar’s investment narrative, particularly around cost control and operational...

MiroliverELAP trial update and why it matters for United Therapeutics (UTHR) United Therapeutics (UTHR) recently reported positive safety and survival findings from a phase 1 study of miroliverELAP, an external liver assist device for acute liver failure patients who are not eligible for transplants. The single arm, open label trial treated five such patients continuously for at least 44 hours. It met its primary survival endpoint during treatment and reported no unexpected serious adverse...

Kimball Electronics (KE) has put out a mixed Q2 2026 update, with revenue of US$341.3 million and basic EPS of US$0.15, alongside trailing twelve month EPS of US$0.98 on US$1.46 billion of revenue that reflects a sharp 199.5% earnings gain over the last year but a longer run of choppy results. The company has seen quarterly revenue move between US$341.3 million and US$380.5 million over the past six reported periods, while basic EPS has ranged from about US$0.13 to US$0.41. This sets the...

In late January 2026, Motorola Solutions launched Assist Suites, a portfolio of role-based AI tools that unify 911 audio, video, radio transcripts and other data to support faster emergency response, officer safety and more accurate reporting for public safety agencies. A key feature, Narrative Assist, cross-references an officer’s account with multiple verified data sources, highlighting discrepancies while preserving human oversight and a full audit trail, which could influence how...

Why Unum Group (UNM) Is On Investors’ Radar Today Unum Group (UNM) is drawing fresh attention after recent share price moves, with the stock showing negative returns over the past week, month, and past 3 months, and a modest positive total return over the past year. See our latest analysis for Unum Group. At a share price of US$75.66, Unum Group’s recent 7 day and 90 day share price returns of 0.83% and 3.19% declines contrast with a 1 year total shareholder return of 0.99% and very strong 3...

Recent share performance and business snapshot Trade Desk (TTD) has seen a series of sharp pullbacks, with the share price down about 4% over the past day and weaker returns over the week, month and past 3 months. The stock is also showing negative year to date and 1 year total returns, despite the company reporting annual revenue of US$2.79b and net income of US$438.58m from its global advertising technology platform. See our latest analysis for Trade Desk. With the share price at US$26.24,...

Edwards Lifesciences (NYSE:EW) is awaiting an FDA decision on its SAPIEN M3 Transcatheter Mitral Valve Replacement system, a potential milestone for its structural heart portfolio. Institutional investors have been building positions around this catalyst, with recent order flow suggesting heightened attention on the upcoming regulatory outcome. The company has also been active with a share repurchase program, signaling confidence from management in the long term outlook. Edwards...

Pentair plc recently reported past fourth-quarter and full-year 2025 results showing higher sales and earnings per share, while also issuing new 2026 guidance and outlining only minor asset impairments of US$600,000. Alongside this, the company unveiled a reshaped leadership structure that elevates digital and AI-focused innovation while eliminating long-standing supply chain and technology officer roles, signaling a shift in how it pursues growth and execution. We’ll now examine how...

Blue Bird (BLBD) has opened fiscal 2026 with Q1 revenue of US$333.1 million and basic EPS of US$0.97, alongside trailing twelve month revenue of about US$1.5 billion and EPS of US$4.09 that reflects a 20% earnings lift over the past year. Over recent quarters, the company has seen revenue move from US$313.9 million in Q1 2025 to US$333.1 million in Q1 2026, while basic EPS shifted from US$0.89 to US$0.97 as net profit margin held in the high single digits. With net profit margin edging up to...

Cavco Industries reported third-quarter 2025 results on January 29, 2026, with sales rising to US$558.5 million while net income and earnings per share from continuing operations declined year over year, even as nine-month figures showed higher sales and net income versus the prior period. The company also disclosed progress on its May 2025 share repurchase plan, having bought back 92,568 shares for US$52.32 million, trimming its share count by just over 1% during a period of mixed quarterly...

Energy Transfer LP recently increased its quarterly cash distribution to US$0.3350 per common unit (US$1.34 annualized) for the fourth quarter of 2025, payable on February 19, 2026 to unitholders of record as of February 6, 2026, marking more than a 3% rise from the prior year’s fourth quarter payout. This distribution hike, paired with management’s plans for multi‑billion dollar pipeline expansion investments and an expressed aim for ongoing distribution growth, highlights Energy Transfer’s...

Why Invesco is on investors’ radar today Invesco (IVZ) has recently drawn attention after a mixed set of financial signals, with annual revenue of US$6,377.1m alongside a net loss of US$726.3m and contrasting short term and longer term share returns. See our latest analysis for Invesco. Short term sentiment has cooled, with a 1 day share price return decline of 3.99% adding to a 7 day and 30 day slide. However, the 90 day share price return of 10.27% and 1 year total shareholder return of...

National Fuel Gas (NFG) has just posted first quarter earnings that included revenue of US$651.51 million and net income of US$181.65 million, along with higher earnings per share compared with the prior year. See our latest analysis for National Fuel Gas. Those stronger quarterly numbers sit alongside a 6.5% 1 month share price return and a 6.7% 3 month share price return. The 1 year total shareholder return of 20.2% and 5 year total shareholder return of 126.0% point to momentum that has...

Marathon Petroleum, ticker NYSE:MPC, has proposed a new four year labor contract to the United Steelworkers union, covering a significant portion of the U.S. refining workforce. At the same time, the company has launched a community investment initiative in California through an educational partnership focused on water recycling with the Water Replenishment District. The dual developments touch both operational labor terms and Marathon's approach to environmental education and community...

Synchrony Financial (NYSE:SYF) reported mixed Q4 results, pairing better-than-expected adjusted earnings per share with a cautious net revenue outlook for 2025. Management highlighted growing digital engagement, new product categories and successful partner renewals as key themes from the quarter. The company also pointed to moderating consumer spending trends and the potential impact of anticipated interest rate cuts on its business. For you as an investor, the current picture around...

Investors may be wondering whether Corporación América Airports still represents good value after its strong share price history, or if most of the opportunity is already reflected in the current US$28.24 price. The stock has had a mixed recent run, with a 7% decline over the last week, a 5.5% gain over the past month, and returns of 6.3% year to date and 42.7% over the last year. Over longer periods, the 3 year gain is very large and the 5 year return is also very large. Recent attention on...

In January 2026, Kirby Corporation reported fourth-quarter 2025 revenue of US$851.78 million and net income of US$91.81 million, alongside continued share repurchases totaling 1,030,729 shares for US$101.60 million in the quarter. Management also projected 2026 operating cash flow of US$575 million to US$675 million and signaled an ongoing focus on both acquisitions and returning cash to shareholders, underscoring an emphasis on capital deployment. With these stronger earnings and Kirby’s...

Recent technical work on CBRE Group (CBRE) has put the stock in focus, with a strong uptrend, high momentum, and sector outperformance drawing investors toward the chart rather than the fundamentals. See our latest analysis for CBRE Group. At a share price of $166.18, CBRE has seen short term pressure, including a 7 day share price return decline of 3.16%, while longer term momentum remains positive, reflected in a 1 year total shareholder return of 14.94% and 5 year total shareholder return...

Barclays analyst Jared Shaw recently downgraded Independent Bank (INDB) to a sell rating, an event that has sharpened investor focus on this regional lender and its role as a conservative, income oriented bank stock. See our latest analysis for Independent Bank. Despite the downgrade, Independent Bank’s recent trading paints a different short term picture, with a 30 day share price return of 13.38% and a year to date share price return of 16.37%, alongside a 1 year total shareholder return of...

In late January 2026, Incyte reported that the EMA’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Zynyz (retifanlimab) plus carboplatin and paclitaxel as first-line treatment for adults with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal, based on Phase 3 data showing improved progression-free survival and no new safety signals. This recommendation underscores Incyte’s effort to broaden its...

If you are wondering whether Bunge Global's share price fairly reflects its business today, you are not alone. This article is here to help you size up what you are actually paying for. The stock closed at US$113.94, with a 1.1% decline over the last 7 days, while returns sit at 20.8% over 30 days, 23.0% year to date, 70.2% over 1 year, 29.5% over 3 years and 71.1% over 5 years. These moves have put Bunge Global back on many investors radars, as they reassess what is already priced into the...